IRWD241220P2500
- 0.05
- 0.000.00%
Ironwood Pharmaceuticals Newsroom
Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Maintains Target Price $12
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Jefferies Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Cuts Target Price to $12
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
JMP Securities Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Maintains Target Price $23
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Capital One Financial Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Cuts Target Price to $5
Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Announces Target Price $12
JMP Securities Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Maintains Target Price $23
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
Leerink Partners Initiates Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Announces Target Price $5
Ironwood Pharmaceuticals Analyst Ratings
Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $10
Ironwood Pharma (IRWD) Gets a Buy From JMP Securities
Ironwood Pharmaceuticals: Hold Rating Amidst Financial and Market Headwinds
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating